The quality of the UK’s scientific research institutions is ranked as the second best in the world, while the UK pharmaceutical industry consistently ranks as the leading sector in the UK for R&D spending.
The evidence for the industry-academia relationship is encouraging, with the pharmaceutical industry and academia collaborating on over 16,000 publications between 2006 and 2015; seven of the top 15 companies for collaborative projects in the UK are found within the pharmaceutical industry.
As a highly valuable two-way exchange of information, the benefits of collaboration are strong for all parties involved. The value that the industry-academia relationship can bring is well recognised, with some companies employing individual project management staff specifically operating on collaboration projects with individual universities.
At the centre of these collaborations are patients, who benefit from this high-level knowledge exchange through greater access to novel therapeutics, and through direct involvement in certain projects, such as patient biobanks.